Categories: HospitalsNews

Senzime Secures Multiple University Hospital Orders in Germany

UPPSALA, SE / ACCESSWIRE / November 30, 2023 / Senzime (STO:SEZI) Senzime, an industry leader in algorithm-based patient monitoring solutions, today announced that it has secured multiple new orders for the TetraGraph system from several German university hospitals. The orders are the result of comprehensive clinical and competitive product evaluations. When fully deployed, these hospitals are expected to generate annual recurring revenue contributing significantly to announced financial targets.

“We continue to demonstrate that we are the trusted vendor of choice for leading hospitals that are starting to operate in the spirit of the new clinical guidelines of objective neuromuscular monitoring on patients receiving neuromuscular blocking drugs. Since our introduction on the German market in early 2021, our sales team has secured nearly 30 major hospital contracts including several key robotic surgery centers. These new orders are important milestones for us and indicators that the new European clinical guidelines are getting implemented in clinical practice”, comments Philip Siberg, CEO of Senzime.

TetraGraph is the first portable electromyography (EMG)-based neuromuscular monitor on the market that is clinically validated and that meets the new clinical guidelines published by ESAIC (European Society of Anaesthesiology and Intensive Care) and the ASA (American Society of Anesthesiologists).

The TetraGraph system is used during surgery to accurately monitor the patient’s level of neuromuscular block. This helps anesthesiologists secure the right dose of neuromuscular blocking drugs and their antagonists during surgery, as well as indicate when it is safe to allow patients to breathe again on their own.

For further information, please contact:

Philip Siberg, CEO of Senzime AB
Phone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com

Attachments

Senzime secures multiple university hospital orders in Germany

SOURCE: Senzime

View source version on accesswire.com:
https://www.accesswire.com/811707/senzime-secures-multiple-university-hospital-orders-in-germany

Staff

Recent Posts

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

7 hours ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

10 hours ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

12 hours ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

13 hours ago

Thought Technology Ltd Celebrates 50 Years of Innovation and Excellence

Montreal-based Thought Technology Ltd wraps up its 50th year in business providing psychophysiological instrumentation to…

13 hours ago

Study Finds Telemedicine Improves Care for Children with Eye Cancer

The new research from eye care nonprofit Orbis International, supported by Heidelberg Engineering, shows how…

13 hours ago